News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Paolo Tarantino: The SERENA6 phase 3 trial is positive
Paolo Tarantino/X
Feb 28, 2025, 08:09

Paolo Tarantino: The SERENA6 phase 3 trial is positive

Paolo Tarantino,  Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X:

“The SERENA6 phase 3 trial is positive: a switch to camizestrant + CDK4/6i (vs continuation of AI + CDK4/6i) upon emergence of ESR1 mutations led to a significant improvement in PFS.

PFS2 and OS, which will be key to interpret the results, remain immature.”

Paolo Tarantino: The SERENA6 phase 3 trial is positive

AI camizestrant cancer CDK4/6i Dana-Farber Cancer Institute ESR1 fight against cancer Global fight against cancer OncoDaily Oncology Paolo Tarantino PFS SERENA6
Special Coverage
Blog
May 10, 2025, 15:01
SIOP Africa 2026 Congress is just 342 days away - The Dorcas Cancer Foundation
Blog
May 10, 2025, 15:01
Susanna Fletcher Greer: Thrilled to Partner with the Cancer Vaccine Coalition
Blog
May 10, 2025, 14:36
Abdulla Alzibdeh: Tumor-Directed SBRT May Enhance Outcomes in LA-NSCLC on Durvalumab
Blog
May 10, 2025, 14:23
GEC-ESTRO Urology: Hathal Haddad Highlights Updates on Urological Cancer Brachytherapy
Blog
May 10, 2025, 14:14
Cizzle Bio Backs ALA’s Call for Broader Insurance Coverage of Biomarker Testing
Blog
May 10, 2025, 14:11
Cancer Awareness and Research Impact Group Launches on World Ovarian Cancer Day
Blog
May 10, 2025, 13:57
David Tougeron Introduces ENGIC – A New European Network for GI Cancers
Blog
May 10, 2025, 13:57
Jasmine Kamboj: We Need to Oppose Any Legislation that Would Reduce Federal Support for Medicaid
Blog
May 10, 2025, 13:48
Catherine Alix-Panabières: We’re Thrilled to Launch the 3rd General Assembly of the GUIDE.MRD IHI Project
Blog
May 10, 2025, 13:02
Danny Burke Shared ecancer’s Free Global Oncology E-Learning on Myelofibrosis and More
Blog
May 10, 2025, 12:49
Guru Sonpavde: New Study on Early Dynamics of Atezolizumab Resistance in Systemic Immunotherapy for Bladder Cancer
Blog
May 10, 2025, 11:51
Hathal Haddad: Celebrating Ina Jürgenliemk-Schulz on receiving the Iridium-192 Award at ESTRO 2025